The maker’s program

Lingo 12-week subscription

Maker’s price from Abbott

For anyone $249 every 12 weeks

6 biosensors every 12 weeks ($41.50 each); a single 2-week biosensor is $54. No prescription; for adults not on insulin.

See it on hellolingo.com 

In the maker’s words

“Auto-renews every 12 weeks at $249 with option to cancel renewal.”

From the maker’s page on hellolingo.com, checked November 17, 2026.

From Abbott’s own website, in its own words. DrugAlt reads each page again every week.

More ways to pay less

What it is

A small sensor worn on the skin that reads glucose (sugar) around the clock and sends the readings to a phone app.

Used for: Seeing when glucose (sugar) levels are normal or out of range, for people who do not use insulin and are not at significant risk of serious low glucose; Glucose readings to review with a health professional before any treatment decision.

In the FDA’s records’ words

Percutaneous interstitial fluid glucose monitoring system, electrochemical. An assembly of electrically-powered, portable devices intended to continuously monitor interstitial fluid glucose concentrations in a patient with diabetes mellitus, using an invasive electrochemical technique. It consists of an electrochemical, percutaneously-inserted electrode that physically connects to a cable or transmitter which communicates with a monitor or receiver (not included) that captures, stores, and converts the sensor signals to glucose concentrations for display. The system may be used in the home and clinical settings, and aids in the detection of episodes of hyperglycaemia and hypoglycaemia, facilitating acute/long-term therapy adjustments.

Integrated continuous glucose monitor for non-intensive glucose monitoring, Over-The-Counter. An integrated continuous glucose monitoring system (iCGM) for non-intensive glucose monitoring is intended to automatically measure glucose in bodily fluids continuously or frequently for a specified period of time to detect euglycemic and dysglycemic glucose levels in persons who are not on insulin and do not have a significant risk of problematic hypoglycemia. iCGM systems for non-intensive glucose monitoring are designed to reliably and securely transmit glucose measurement data to digitally connected devices, excluding devices intended to control the delivery of insulin, and are intended to be used alone or in conjunction with these digitally connected medical devices. Device output should not be used to make treatment decisions without consulting with a qualified healthcare professional.

Only your prescriber can say whether a device is right for you.

In the FDA’s device database

3 versions sold now

Each opens its FDA record. The model number is on the box.

Source: the FDA’s device database (GUDID), November 2, 2026.

Similar devices

All 9 continuous glucose monitors